Meropenem Steriscience (Meropenem)

Meropenem is a broad‑spectrum carbapenem used for serious infections that require intravenous therapy.

• Complicated intra‑abdominal infection: provides coverage against Gram‑negative, Gram‑positive and anaerobic bacteria.
• Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: targets resistant respiratory pathogens.
• Complicated urinary tract infection: eradicates multidrug‑resistant uropathogens.
• Sepsis and septic shock: delivers rapid bactericidal activity in systemic infections.
• Meningitis caused by susceptible organisms: penetrates the cerebrospinal fluid to treat central nervous system infections.

• Meropenem binds to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. Its high affinity for a broad range of PBPs underlies its activity against many Gram‑negative, Gram‑positive and anaerobic organisms, including many resistant strains.

Meropenem may cause a range of adverse reactions, most of which are dose‑independent.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Diarrhea: may be watery and occasionally associated with Clostridioides difficile.
• Headache: transient and usually resolves without intervention.
• Injection site pain: localized discomfort at the infusion site.
• Elevated liver enzymes: transient increase in transaminases.
• Rash: mild erythematous skin eruption.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Seizures: especially in patients with renal impairment or high doses.
• Hemolytic anemia: immune‑mediated destruction of red blood cells.
• Thrombocytopenia: reduced platelet count that may increase bleeding risk.
• Acute interstitial nephritis: inflammation of kidney interstitium.
• Stevens‑Johnson syndrome: rare severe mucocutaneous reaction.

When using Meropenem, clinicians should consider several safety measures.

• Renal function: adjust dose in patients with impaired kidney function.
• History of seizures: monitor closely as the drug can lower seizure threshold.
• Allergies: avoid in individuals with known hypersensitivity to carbapenems or beta‑lactams.
• Pregnancy and lactation: use only if the potential benefit justifies the potential risk.
• Concomitant nephrotoxic drugs: monitor renal parameters when combined with other nephrotoxic agents.
• Store below 25°C: keep in the original container, protect from moisture and light.

Meropenem can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: concomitant use may reduce valproate levels and increase seizure risk.
• Probenecid: may decrease renal clearance of meropenem, leading to higher plasma concentrations.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: combined nephrotoxic potential requires renal function monitoring.
• Loop diuretics: may enhance ototoxicity when used with other ototoxic agents.
• Anticoagulants (e.g., warfarin): monitor INR as infection control may alter coagulation parameters.